R&D | April 16, 2026
NIPER Mohali, Novartis Healthcare sign pact to boost pharma R&D innovation
The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs
The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem
A nationwide network of over 1,000 accredited clinical trial sites will be created to accelerate drug development timelines and enhance research credibility
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
The Union Budget 2026–27 accords strong priority to the upgradation and expansion of healthcare infrastructure and medical education
The segment has immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities
Target identification will commence on 17 September 2024, following the timeline provided in the campaign guidelines
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
Subscribe To Our Newsletter & Stay Updated
